Dan Rose is the current CEO at LimFlow SA, a medical device company that focuses on providing revolutionary solutions for critical limb ischemia. With over two decades of leadership experience in the healthcare industry, Rose is a seasoned executive with a passion for developing breakthrough technologies that enhance patient outcomes.

Prior to joining LimFlow SA, Dan Rose served as CEO of TNI BioTech Inc., where he spearheaded strategic initiatives that led to profound growth for the company. He also held leadership positions in renowned medical institutions such as American Institute of Biological Sciences, where he served as Managing Director, as well as US Oncology, where he provided guidance as Vice President of Strategic Initiatives.

Throughout his career, Rose has been recognized for his exceptional leadership skills, strategic vision, and keen business acumen. He leverages his extensive experience to drive company growth and create value for all stakeholders.